Home Data Calendar Blog

OVID

Tables

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Common Stock Value 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06

Weighted Average Number Of Diluted Shares Outstanding NA 70.43 70.39 70.35 NA 67.93 67.82 66.58 NA 59.41

Weighted Average Number Of Shares Outstanding Basic NA 70.43 70.39 70.35 NA 67.93 67.82 66.09 NA 59.41

Earnings Per Share Basic -0.16 -0.17 -0.21 -0.23 -0.37 -0.17 -0.23 2.55 -0.35 -0.28

Earnings Per Share Diluted -0.16 -0.17 -0.21 -0.23 -0.38 -0.17 -0.23 2.53 -0.35 -0.28

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Common Stock Value	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.06
Weighted Average Number Of Diluted Shares Outstanding	NA	70.43	70.39	70.35	NA	67.93	67.82	66.58	NA	59.41
Weighted Average Number Of Shares Outstanding Basic	NA	70.43	70.39	70.35	NA	67.93	67.82	66.09	NA	59.41
Earnings Per Share Basic	-0.16	-0.17	-0.21	-0.23	-0.37	-0.17	-0.23	2.55	-0.35	-0.28
Earnings Per Share Diluted	-0.16	-0.17	-0.21	-0.23	-0.38	-0.17	-0.23	2.53	-0.35	-0.28

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Revenue From Contract With Customer Excluding Assessed Tax 0.05 0.01 0.00 1.45 0.00 0.00 0.00 208.38 5.70 6.91

Revenue From Contract With Customer Including Assessed Tax 0.05 0.01 0.00 1.45 0.00 0.00 0.00 208.38 5.70 6.91

Revenues 0.05 0.01 0.00 1.45 0.00 0.00 0.00 208.38 5.70 6.91

Operating Expenses 12.22 12.81 14.30 17.71 26.35 11.68 14.31 31.83 27.29 23.32

Research And Development Expense 5.56 5.18 6.05 7.83 18.09 4.92 7.68 16.25 16.88 15.88

General And Administrative Expense 6.66 7.63 8.26 9.88 8.26 6.76 6.63 15.58 10.41 7.44

Operating Income Loss -12.17 -12.80 -14.30 -16.27 -26.35 -11.68 -14.31 176.56 -21.59 -16.40

Allocated Share Based Compensation Expense 1.73 1.78 1.72 1.32 1.32 1.16 1.26 1.32 2.05 2.62

Income Tax Expense Benefit NA NA NA 0.05 -0.35 -0.29 1.47 0.50 NA NA

Net Income Loss -11.50 -11.97 -14.59 -16.11 -26.00 -11.38 -15.79 176.01 -22.03 -16.42

Comprehensive Income Net Of Tax -11.46 -11.96 -14.68 NA -26.00 -11.38 -15.79 176.01 -22.03 -16.42

Net Income Loss Available To Common Stockholders Basic -11.50 -11.97 -14.59 -16.11 -25.15 -11.38 -15.79 168.57 -22.03 -16.42

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Revenue From Contract With Customer Excluding Assessed Tax	0.05	0.01	0.00	1.45	0.00	0.00	0.00	208.38	5.70	6.91
Revenue From Contract With Customer Including Assessed Tax	0.05	0.01	0.00	1.45	0.00	0.00	0.00	208.38	5.70	6.91
Revenues	0.05	0.01	0.00	1.45	0.00	0.00	0.00	208.38	5.70	6.91
Operating Expenses	12.22	12.81	14.30	17.71	26.35	11.68	14.31	31.83	27.29	23.32
Research And Development Expense	5.56	5.18	6.05	7.83	18.09	4.92	7.68	16.25	16.88	15.88
General And Administrative Expense	6.66	7.63	8.26	9.88	8.26	6.76	6.63	15.58	10.41	7.44
Operating Income Loss	-12.17	-12.80	-14.30	-16.27	-26.35	-11.68	-14.31	176.56	-21.59	-16.40
Allocated Share Based Compensation Expense	1.73	1.78	1.72	1.32	1.32	1.16	1.26	1.32	2.05	2.62
Income Tax Expense Benefit	NA	NA	NA	0.05	-0.35	-0.29	1.47	0.50	NA	NA
Net Income Loss	-11.50	-11.97	-14.59	-16.11	-26.00	-11.38	-15.79	176.01	-22.03	-16.42
Comprehensive Income Net Of Tax	-11.46	-11.96	-14.68	NA	-26.00	-11.38	-15.79	176.01	-22.03	-16.42
Net Income Loss Available To Common Stockholders Basic	-11.50	-11.97	-14.59	-16.11	-25.15	-11.38	-15.79	168.57	-22.03	-16.42

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Assets 155.27 165.03 177.33 191.10 194.54 207.09 218.00 237.46 75.93 91.60

Liabilities 22.99 22.98 25.18 26.10 14.80 10.06 11.29 16.35 32.29 27.96

Liabilities And Stockholders Equity 155.27 165.03 177.33 191.10 194.54 207.09 218.00 237.46 75.93 91.60

Stockholders Equity 132.27 142.05 152.15 165.00 179.75 197.02 206.71 221.11 43.63 63.64

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Assets	155.27	165.03	177.33	191.10	194.54	207.09	218.00	237.46	75.93	91.60
Liabilities	22.99	22.98	25.18	26.10	14.80	10.06	11.29	16.35	32.29	27.96
Liabilities And Stockholders Equity	155.27	165.03	177.33	191.10	194.54	207.09	218.00	237.46	75.93	91.60
Stockholders Equity	132.27	142.05	152.15	165.00	179.75	197.02	206.71	221.11	43.63	63.64

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Assets Current 131.38 140.50 156.08 170.09 190.48 205.06 215.87 236.66 74.84 90.35

Cash And Cash Equivalents At Carrying Value 44.87 58.26 72.81 166.67 187.80 201.78 212.17 233.05 72.03 86.87

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 46.80 60.19 74.74 168.60 189.73 201.78 212.17 233.05 72.03 86.87

Prepaid Expense And Other Assets Current 2.38 2.64 2.72 2.42 2.68 3.28 3.71 2.59 2.67 2.83

Available For Sale Securities Debt Securities 84.10 79.60 79.55 NA NA NA NA NA NA NA

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Assets Current	131.38	140.50	156.08	170.09	190.48	205.06	215.87	236.66	74.84	90.35
Cash And Cash Equivalents At Carrying Value	44.87	58.26	72.81	166.67	187.80	201.78	212.17	233.05	72.03	86.87
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents	46.80	60.19	74.74	168.60	189.73	201.78	212.17	233.05	72.03	86.87
Prepaid Expense And Other Assets Current	2.38	2.64	2.72	2.42	2.68	3.28	3.71	2.59	2.67	2.83
Available For Sale Securities Debt Securities	84.10	79.60	79.55	NA	NA	NA	NA	NA	NA	NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 0.58 0.45 0.35 0.29 0.26 0.24 0.22 0.20 0.19 0.17

Amortization Of Intangible Assets 0.05 0.05 0.03 0.03 0.03 0.04 0.04 0.06 0.07 0.06

Property Plant And Equipment Net 1.15 1.16 1.24 0.26 0.24 0.10 0.11 0.13 0.14 0.14

Long Term Investments 5.62 5.95 2.23 2.78 1.63 1.63 1.61 NA NA NA

Finite Lived Intangible Assets Net 0.22 0.28 0.33 0.24 0.16 0.20 0.23 0.26 0.32 0.36

Other Assets Noncurrent 0.26 0.28 0.33 0.24 0.16 0.20 0.23 0.26 0.32 0.36

Available For Sale Debt Securities Amortized Cost Basis 84.18 79.68 79.64 NA NA NA NA NA NA NA

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment	0.58	0.45	0.35	0.29	0.26	0.24	0.22	0.20	0.19	0.17
Amortization Of Intangible Assets	0.05	0.05	0.03	0.03	0.03	0.04	0.04	0.06	0.07	0.06
Property Plant And Equipment Net	1.15	1.16	1.24	0.26	0.24	0.10	0.11	0.13	0.14	0.14
Long Term Investments	5.62	5.95	2.23	2.78	1.63	1.63	1.61	NA	NA	NA
Finite Lived Intangible Assets Net	0.22	0.28	0.33	0.24	0.16	0.20	0.23	0.26	0.32	0.36
Other Assets Noncurrent	0.26	0.28	0.33	0.24	0.16	0.20	0.23	0.26	0.32	0.36
Available For Sale Debt Securities Amortized Cost Basis	84.18	79.68	79.64	NA	NA	NA	NA	NA	NA	NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Liabilities Current 6.99 NA NA NA 14.80 10.06 11.29 16.35 22.06 17.96

Accounts Payable Current 1.95 1.03 4.62 2.26 7.13 3.14 0.91 3.15 5.45 3.16

Other Accrued Liabilities Current 0.19 0.55 0.28 0.14 0.55 0.12 1.96 0.67 0.17 0.27

Accrued Liabilities Current 4.50 5.70 4.60 7.97 7.67 6.92 10.38 13.20 12.03 11.42

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Liabilities Current	6.99	NA	NA	NA	14.80	10.06	11.29	16.35	22.06	17.96
Accounts Payable Current	1.95	1.03	4.62	2.26	7.13	3.14	0.91	3.15	5.45	3.16
Other Accrued Liabilities Current	0.19	0.55	0.28	0.14	0.55	0.12	1.96	0.67	0.17	0.27
Accrued Liabilities Current	4.50	5.70	4.60	7.97	7.67	6.92	10.38	13.20	12.03	11.42

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Operating Lease Liability Noncurrent 16.00 16.25 15.97 15.87 NA NA NA NA NA NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Operating Lease Liability Noncurrent		16.00	16.25	15.97	15.87	NA	NA	NA	NA	NA	NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Stockholders Equity 132.27 142.05 152.15 165.00 179.75 197.02 206.71 221.11 43.63 63.64

Common Stock Value 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06

Additional Paid In Capital 357.77 NA NA NA 351.03 NA NA NA NA NA

Additional Paid In Capital Common Stock NA 356.08 354.22 352.39 351.03 342.31 340.61 339.23 337.76 335.74

Retained Earnings Accumulated Deficit -225.53 -214.02 -202.05 -187.47 -171.36 -145.36 -133.97 -118.18 -294.19 -272.16

Accumulated Other Comprehensive Income Loss Net Of Tax -0.04 -0.08 -0.09 NA NA NA NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA 1.78 1.72 1.32 NA 1.16 1.26 1.32 NA 2.62

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Stockholders Equity	132.27	142.05	152.15	165.00	179.75	197.02	206.71	221.11	43.63	63.64
Common Stock Value	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.06
Additional Paid In Capital	357.77	NA	NA	NA	351.03	NA	NA	NA	NA	NA
Additional Paid In Capital Common Stock	NA	356.08	354.22	352.39	351.03	342.31	340.61	339.23	337.76	335.74
Retained Earnings Accumulated Deficit	-225.53	-214.02	-202.05	-187.47	-171.36	-145.36	-133.97	-118.18	-294.19	-272.16
Accumulated Other Comprehensive Income Loss Net Of Tax	-0.04	-0.08	-0.09	NA	NA	NA	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value	NA	1.78	1.72	1.32	NA	1.16	1.26	1.32	NA	2.62

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Operating Activities -9.18 -12.68 -13.29 -20.09 -12.00 -10.87 -19.42 160.90 -14.51 -1.47

Net Cash Provided By Used In Investing Activities -4.17 -1.96 -80.68 -1.08 -0.16 -0.06 -1.58 -0.01 -0.09 -0.04

Net Cash Provided By Used In Financing Activities -0.04 0.08 0.11 0.03 0.11 0.55 0.12 0.13 -0.23 47.12

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Operating Activities	-9.18	-12.68	-13.29	-20.09	-12.00	-10.87	-19.42	160.90	-14.51	-1.47
Net Cash Provided By Used In Investing Activities	-4.17	-1.96	-80.68	-1.08	-0.16	-0.06	-1.58	-0.01	-0.09	-0.04
Net Cash Provided By Used In Financing Activities	-0.04	0.08	0.11	0.03	0.11	0.55	0.12	0.13	-0.23	47.12

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Operating Activities -9.18 -12.68 -13.29 -20.09 -12.00 -10.87 -19.42 160.90 -14.51 -1.47

Net Income Loss -11.50 -11.97 -14.59 -16.11 -26.00 -11.38 -15.79 176.01 -22.03 -16.42

Depreciation Depletion And Amortization 0.18 0.16 0.10 0.07 0.06 0.05 0.05 0.07 0.08 0.08

Share Based Compensation 1.73 1.78 1.72 1.32 1.32 1.16 1.26 1.32 2.05 2.62

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Operating Activities	-9.18	-12.68	-13.29	-20.09	-12.00	-10.87	-19.42	160.90	-14.51	-1.47
Net Income Loss	-11.50	-11.97	-14.59	-16.11	-26.00	-11.38	-15.79	176.01	-22.03	-16.42
Depreciation Depletion And Amortization	0.18	0.16	0.10	0.07	0.06	0.05	0.05	0.07	0.08	0.08
Share Based Compensation	1.73	1.78	1.72	1.32	1.32	1.16	1.26	1.32	2.05	2.62

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Investing Activities -4.17 -1.96 -80.68 -1.08 -0.16 -0.06 -1.58 -0.01 -0.09 -0.04

Payments To Acquire Property Plant And Equipment 0.12 0.02 1.04 0.05 0.16 0.01 0.00 0.01 0.04 0.02

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Investing Activities		-4.17	-1.96	-80.68	-1.08	-0.16	-0.06	-1.58	-0.01	-0.09	-0.04
Payments To Acquire Property Plant And Equipment		0.12	0.02	1.04	0.05	0.16	0.01	0.00	0.01	0.04	0.02

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Financing Activities -0.04 0.08 0.11 0.03 0.11 0.55 0.12 0.13 -0.23 47.12

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Financing Activities		-0.04	0.08	0.11	0.03	0.11	0.55	0.12	0.13	-0.23	47.12

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Revenues 0.05 0.01 0.00 1.45 0.00 0.00 0.00 208.38 5.70 6.91

Marinus Pharmaceuticals Inc, Patent License Agreement NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Excluding Assessed Tax 0.05 0.01 0.00 1.45 0.00 0.00 0.00 208.38 5.70 6.91

Marinus Pharmaceuticals Inc, Patent License Agreement NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Including Assessed Tax 0.05 0.01 0.00 1.45 0.00 0.00 0.00 208.38 5.70 6.91

Marinus Pharmaceuticals Inc, Patent License Agreement NA NA NA NA NA NA NA NA NA NA

License 0.05 0.01 0.00 1.45 0.00 0.00 0.00 12.38 5.70 6.91

Healx License And Option Agreement NA 0.00 0.00 0.50 NA NA NA NA NA NA

	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Revenues	0.05	0.01	0.00	1.45	0.00	0.00	0.00	208.38	5.70	6.91
Marinus Pharmaceuticals Inc, Patent License Agreement	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax	0.05	0.01	0.00	1.45	0.00	0.00	0.00	208.38	5.70	6.91
Marinus Pharmaceuticals Inc, Patent License Agreement	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Including Assessed Tax	0.05	0.01	0.00	1.45	0.00	0.00	0.00	208.38	5.70	6.91
Marinus Pharmaceuticals Inc, Patent License Agreement	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
License	0.05	0.01	0.00	1.45	0.00	0.00	0.00	12.38	5.70	6.91
Healx License And Option Agreement	NA	0.00	0.00	0.50	NA	NA	NA	NA	NA	NA

Plots across concepts

IncomeStatement

Expenses

Balance Sheet

Assets

Current Assets

NonCurrent Assets

PropertyPlantAndEquipmentNet

Liabilities

Current Liabilities

Stockholders Equity

CashFlow

NetCashProvidedByUsedInOperatingActivities

NetCashProvidedByUsedInInvestingActivities

OperatingLeaseLiability

LesseeOperatingLeaseLiabilityPaymentsDue

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

us-gaap:StockholdersEquity
us-gaap:StatementClassOfStock, us-gaap:StatementEquityComponents
(None, 'us-gaap:PreferredStock')

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:CashAndCashEquivalents
(None,)

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)